Compare Cipla with Sterling Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIPLA vs STERLING BIOTECH - Comparison Results

CIPLA     Change

Cipla is one of the largest pharma companies in the domestic market and has presence in formulations and bulk drugs manufacturing. All the bulk drug manufacturing facilities of the company have been approved by various authorities including the US FD... More

STERLING BIOTECH 
   Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CIPLA STERLING BIOTECH CIPLA/
STERLING BIOTECH
 
P/E (TTM) x 34.2 -0.4 - View Chart
P/BV x 4.8 0.0 33,971.8% View Chart
Dividend Yield % 0.4 0.0 -  

Financials

 CIPLA   STERLING BIOTECH
EQUITY SHARE DATA
    CIPLA
Mar-20
STERLING BIOTECH
Dec-13
CIPLA/
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs58611 5,576.2%   
Low Rs3573 10,494.1%   
Sales per share (Unadj.) Rs207.026.8 772.4%  
Earnings per share (Unadj.) Rs18.6-15.0 -124.3%  
Cash flow per share (Unadj.) Rs33.2-5.5 -607.1%  
Dividends per share (Unadj.) Rs4.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs195.554.9 356.2%  
Shares outstanding (eoy) m806.35267.87 301.0%   
Bonus/Rights/Conversions ESOS--  
Price / Sales ratio x2.30.3 877.7%   
Avg P/E ratio x25.3-0.5 -5,452.4%  
P/CF ratio (eoy) x14.2-1.3 -1,116.7%  
Price / Book Value ratio x2.40.1 1,903.2%  
Dividend payout %21.50-   
Avg Mkt Cap Rs m379,9121,862 20,406.7%   
No. of employees `00025.81.4 1,908.8%   
Total wages/salary Rs m30,270547 5,535.9%   
Avg. sales/employee Rs Th6,459.65,303.3 121.8%   
Avg. wages/employee Rs Th1,171.2403.8 290.0%   
Avg. net profit/employee Rs Th580.2-2,959.0 -19.6%   
INCOME DATA
Net Sales Rs m166,9497,181 2,325.0%  
Other income Rs m3,44243 8,079.8%   
Total revenues Rs m170,3917,223 2,358.9%   
Gross profit Rs m32,060947 3,385.8%  
Depreciation Rs m11,7472,543 461.9%   
Interest Rs m1,9744,377 45.1%   
Profit before tax Rs m21,782-5,931 -367.3%   
Minority Interest Rs m-4750-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6,312-1,924 -328.0%   
Profit after tax Rs m14,995-4,007 -374.3%  
Gross profit margin %19.213.2 145.6%  
Effective tax rate %29.032.4 89.3%   
Net profit margin %9.0-55.8 -16.1%  
BALANCE SHEET DATA
Current assets Rs m117,03814,335 816.5%   
Current liabilities Rs m43,93149,809 88.2%   
Net working cap to sales %43.8-494.0 -8.9%  
Current ratio x2.70.3 925.7%  
Inventory Days Days96403 23.7%  
Debtors Days Days85171 49.9%  
Net fixed assets Rs m107,42455,432 193.8%   
Share capital Rs m1,613268 601.9%   
"Free" reserves Rs m156,01813,935 1,119.6%   
Net worth Rs m157,63014,701 1,072.2%   
Long term debt Rs m23,6939,478 250.0%   
Total assets Rs m236,62673,988 319.8%  
Interest coverage x12.0-0.4 -3,391.0%   
Debt to equity ratio x0.20.6 23.3%  
Sales to assets ratio x0.70.1 727.0%   
Return on assets %7.20.5 1,431.7%  
Return on equity %9.5-27.3 -34.9%  
Return on capital %12.8-6.4 -199.8%  
Exports to sales %33.025.9 127.6%   
Imports to sales %00.2 0.0%   
Exports (fob) Rs m55,1751,860 2,966.7%   
Imports (cif) Rs mNA12 0.0%   
Fx inflow Rs m56,0361,860 3,013.0%   
Fx outflow Rs m6,76425 27,176.0%   
Net fx Rs m49,2721,835 2,685.2%   
CASH FLOW
From Operations Rs m30,6851,719 1,785.3%  
From Investments Rs m1,040-3,148 -33.0%  
From Financial Activity Rs m-29,4881,426 -2,067.9%  
Net Cashflow Rs m2,340-3 -68,829.4%  

Share Holding

Indian Promoters % 16.0 33.9 47.2%  
Foreign collaborators % 20.8 0.0 -  
Indian inst/Mut Fund % 12.2 0.0 -  
FIIs % 23.7 9.9 239.4%  
ADR/GDR % 1.1 16.9 6.5%  
Free float % 26.2 39.3 66.7%  
Shareholders   161,166 21,482 750.2%  
Pledged promoter(s) holding % 0.0 55.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CIPLA With:   PFIZER  ABBOTT INDIA  PANACEA BIOTECH  PROCTER & GAMBLE HEALTH  GSK PHARMA  

Compare CIPLA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

6 Reasons Why Sensex Plunged 883 Points Today(Closing)

Indian share markets nosedived and registered sharp losses in today's volatile session following a strong second wave of Covid-19 in the country.

Related Views on News

CIPLA Announces Quarterly Results (3QFY21); Net Profit Up 112.8% (Quarterly Result Update)

Feb 1, 2021 | Updated on Feb 1, 2021

For the quarter ended December 2020, CIPLA has posted a net profit of Rs 8 bn (up 112.8% YoY). Sales on the other hand came in at Rs 52 bn (up 18.2% YoY). Read on for a complete analysis of CIPLA's quarterly results.

CIPLA 2019-20 Annual Report Analysis (Annual Result Update)

Nov 4, 2020 | Updated on Nov 4, 2020

Here's an analysis of the annual report of CIPLA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of CIPLA. Also includes updates on the valuation of CIPLA.

CIPLA Announces Quarterly Results (1QFY21); Net Profit Up 21.4% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, CIPLA has posted a net profit of Rs 6 bn (up 21.4% YoY). Sales on the other hand came in at Rs 43 bn (up 7.2% YoY). Read on for a complete analysis of CIPLA's quarterly results.

CIPLA Announces Quarterly Results (4QFY20); Net Profit Down 35.1% (Quarterly Result Update)

May 19, 2020 | Updated on May 19, 2020

For the quarter ended March 2020, CIPLA has posted a net profit of Rs 2 bn (down 35.1% YoY). Sales on the other hand came in at Rs 44 bn (down 0.6% YoY). Read on for a complete analysis of CIPLA's quarterly results.

CIPLA Announces Quarterly Results (3QFY20); Net Profit Up 9.4% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, CIPLA has posted a net profit of Rs 4 bn (up 9.4% YoY). Sales on the other hand came in at Rs 44 bn (up 9.1% YoY). Read on for a complete analysis of CIPLA's quarterly results.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave(Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

A Stock with 700% Return Potential Comes with Additional Payoffs(Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

Why Did the Market Crash on Monday?(Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

A Unique Sector for Short-Term Profits(Fast Profits Daily)

Apr 12, 2021

This ignored sector could deliver big short-term profits.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

CIPLA SHARE PRICE


Apr 19, 2021 (Close)

TRACK CIPLA

COMPARE CIPLA WITH

MARKET STATS